Wolff-Parkinson-White syndrome in the elderly
Preexcitation syndrome is a clinical syndrome with abnormal atrioventricular conduction pathway as pathological basis, abnormal electrophysiological manifestations and easy combination of multiple rapid arrhythmias. It was first reported by White, Parkison and Wolff in 1930, so it is called (WPW syndrome). In 1944, Ohnell proposed the term "preexcitation".
-
Site of disease:
heart -
Infectious :
Not contagious -
Frequent population:
Elderly -
Related symptoms:
Palpitations Neonatal heart failure Ventricular fibrillation Palpitations Low blood pressure -
Concurrent disease:
Related Drugs
Amiodarone Hydrochloride Tablets
Indication: Oral administration is suitable for the prevention of life-threatening paroxysmal ventricular tachycardia and ventricular fibrillation. It can also be used for paroxysmal supraventricular tachycardia, paroxysmal atrial flutter, and atrial fibrillation that are ineffective with other drugs, including those with preexcitation syndrome and maintenance treatment after electrical cardioversion of persistent atrial fibrillation and atrial flutter. It can be used to control the ventricular rate during persistent atrial fibrillation and atrial flutter. It is generally not suitable for the treatment of atrial and ventricular premature beats unless there are clear indications.
Manufacturer:
Hainan Pharmaceutical Factory Co., Ltd. Pharmaceutical Factory No.1
Apridin Hydrochloride Tablets
Indication: Used for frequent ventricular and atrial premature contractions, paroxysmal ventricular and atrial tachycardia, preexcitation syndrome, tachycardia, etc.
Manufacturer:
Hebei Huaweiman Pharmaceutical Co., Ltd.
Amiodarone Hydrochloride Capsules
Indication: Oral administration is suitable for the prevention of life-threatening paroxysmal ventricular tachycardia and ventricular fibrillation. It can also be used for paroxysmal supraventricular tachycardia, paroxysmal atrial flutter, and atrial fibrillation that are ineffective with other drugs, including those with preexcitation syndrome and maintenance treatment after electrical cardioversion of persistent atrial fibrillation and atrial flutter. It can be used to control the ventricular rate during persistent atrial fibrillation and atrial flutter. It is generally not suitable for the treatment of atrial and ventricular premature beats unless there are clear indications.
Manufacturer:
THE Central Pharmaceutical Co., Ltd.
Propafenone Hydrochloride Capsules
Indication: Used for paroxysmal ventricular tachycardia and supraventricular tachycardia (including those with preexcitation syndrome).
Manufacturer:
Shanghai Sine WANXIANG Pharmaceuticals Co., Ltd.
Related Ingredients
-
Amiodarone hydrochloride list
19774-82-4 -
APRINDINE HCL list
33237-74-0 -
Propafenone list
54063-53-5